Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Alviggi C, et al. Among authors: buhler k. Fertil Steril. 2018 Apr;109(4):644-664. doi: 10.1016/j.fertnstert.2018.01.003. Fertil Steril. 2018. PMID: 29653717 Free article.
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management.
Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, Andersen CY, Bühler K, Sunkara SK, Polyzos NP, Strina I, Carbone L, Bento FC, Galliano D, Yarali H, Vuong LN, Grynberg M, Drakopoulos P, Xavier P, Llacer J, Neuspiller F, Horton M, Roque M, Papanikolaou E, Banker M, Dahan MH, Foong S, Tournaye H, Blockeel C, Vaiarelli A, Humaidan P, Ubaldi FM; POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group. Alviggi C, et al. Among authors: buhler k. Reprod Biol Endocrinol. 2020 May 13;18(1):45. doi: 10.1186/s12958-020-00605-z. Reprod Biol Endocrinol. 2020. PMID: 32404170 Free PMC article.
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.
Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, Bühler K, Sunkara SK, Polyzos NP, Galliano D, Grynberg M, Yarali H, Özbek IY, Roque M, Vuong LN, Banker M, Rienzi L, Vaiarelli A, Cimadomo D, Ubaldi FM. Esteves SC, et al. Among authors: buhler k. Front Endocrinol (Lausanne). 2019 Nov 20;10:814. doi: 10.3389/fendo.2019.00814. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31824427 Free PMC article.
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
Bühler KF, Fischer R, Verpillat P, Allignol A, Guedes S, Boutmy E, Bilger W, Richter E, D'Hooghe T. Bühler KF, et al. Reprod Biol Endocrinol. 2021 Jun 16;19(1):90. doi: 10.1186/s12958-021-00768-3. Reprod Biol Endocrinol. 2021. PMID: 34134695 Free PMC article.
Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE.
Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, de Mouzon J, Castilla JA, Erb K, Korsak V, Nyboe Andersen A; European IVF-Monitoring (EIM) Consortium for the European Society of Human Reproduction and Embryology (ESHRE). Ferraretti AP, et al. Hum Reprod. 2013 Sep;28(9):2318-31. doi: 10.1093/humrep/det278. Epub 2013 Jul 9. Hum Reprod. 2013. PMID: 23842560
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.
Bühler K, Roeder C, Schwarze JE, Lispi M, Allignol A, Falla E, Lukyanov V, D Hooghe T, Fischer R. Bühler K, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):188-202. doi: 10.1016/j.bpobgyn.2022.02.002. Epub 2022 Feb 16. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35304097 Free article.
260 results